Navigation Links
Accuray Unveils CyberKnife and TomoTherapy Product Enhancements and Service Offerings at ASTRO 2011
Date:10/3/2011

tient —from the treatment of small, early-stage and localized lesions to large, complex and metastasized disease," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray. "Global customer adoption, coupled with a growing body of clinical evidence supporting use for an expanding number of indications, make CyberKnife and TomoTherapy truly leading-edge solutions for radiation oncology."

In its booth, Accuray will showcase several new product enhancements for both the CyberKnife and TomoTherapy Systems. These innovations include:

  • CyberKnife Lung Optimized Treatment - an improved second generation suite of lung simulation and treatment products provides an optimum fiducial-free treatment option for every lung SBRT patient – regardless of tumor location.
  • CyberKnife Xsight® Spine Prone - in combination with the Synchrony® Respiratory Tracking System, this new tracking product enables clinicians to deliver accurate, non-invasive spine radiosurgery to patients in the prone position to maximize sparing of the spinal cord and other surrounding tissues.
  • TomoTherapy OIS Connect™ & CyberKnife Radiosurgery DICOM Interface - Integrates Accuray Treatment Systems with the oncology department's ARIA® and MOSAIQ® Oncology Information Systems, streamlining workflow and improving operational efficiency.
  • TomoTherapy Hi·Art® V4.1 / TomoHD™ V1.1- The latest versions of the TomoTherapy System software, which include enhancements that improve clinical workflow and efficiency throughout the TomoTherapy process – from treatment planning to delivery.
  • TomoTherapy Remote Software Solutions - Provides the power to develop more TomoTherapy treatment plans, from more places. This remote access solution is flexible, economical and secure and helps treatment centers using Tomo
    '/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Accuray Incorporated to Speak at JMP Securities Healthcare Conference
2. Accuray Hires Chief Commercial Officer
3. Accuray Announces Results for Fourth Quarter and Fiscal Year 2011
4. Accuray Incorporated to Speak at UBS Global Life Sciences Conference
5. Accuray Extends Industry-Leading Customer Service Program to TomoTherapy Systems
6. Accuray Launches New Organization for CyberKnife® and TomoTherapy® System Users
7. Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer
8. Accuray Incorporated to Host Investor Meeting at ASTRO 2011
9. Accuray Symposium Puts Spotlight on Quality Assurance in Radiation Oncology at Joint AAPM/COMP Meeting
10. Accuray Announces Proposed Offering of $75 Million Convertible Senior Notes
11. Accuray Hosts Symposium on Quality Assurance in Radiation Oncology at Joint AAPM/COMP Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... DALLAS , April 1, 2015 /PRNewswire/ ... Research Report on Global Azithromycin Industry and ... Drug Industry reports added to Pharmaceutical category ... analysis, the report introduces Azithromycin basic information, ... industry overview, policy analysis, and news analysis, ...
(Date:4/1/2015)... 1, 2015 Jintian Pharmaceutical Group Limited ("Jintian ... Mr. Jin Dongtao, chairman and executive director purchased 40,000,000 ... of the existing entire issued share capital of the ... with the total amount of approximately HK$113 million. Upon ... will increase from 45.17% to 47.17%. ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and Markets ... the "An Introduction to the Medical Device Directives" ... provides a detailed introduction to the European medical device ... are covered, the involvement of Notified Bodies, how to ... It will also cover the documentation necessary to apply ...
Breaking Medicine Technology:Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2
... Inc. (NYSE: WPI ) today announced ... reached a settlement with Mallinckrodt Inc. on outstanding ... Mallinckrodt,s Exalgo® (Hydromorphone Hydrochloride Extended-Release ) tablets.  Mallinckrodt ... the United States District Court for the District ...
... Pa., Jan. 26, 2012   ProPhase Labs, Inc., the ... October, November and December winners of its "Share Your Cause ... provides financial aid on charitable work in US communities, has ... Buddies of Milwaukie, OR; and Hannah,s Home of Mentor, OH ...
Cached Medicine Technology:Watson Reaches Settlement with Mallinckrodt Over Exalgo(R) 2Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign 2Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign 3Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign 4
(Date:4/1/2015)... 2015 Taking an important step forward ... for Nursing Commission for Nursing Education Accreditation (NLN CNEA) ... first NLN CNEA Board of Commissioners. Working with executive ... 15-member board will provide leadership and direction to accreditation ... decisions for nursing programs that seek accreditation from the ...
(Date:4/1/2015)... IL, Bethesda, MD, Alexandria, VA (PRWEB) April 01, ... Clinical Pathology (ASCP), the College of American Pathologists ... the American Society of Clinical Oncology (ASCO) today ... on the use of molecular marker testing for ... evidence-based guideline will help establish standard molecular marker ...
(Date:4/1/2015)... April 01, 2015 Dr Roz Kamani, ... she is now offering her patients an opportunity to ... can participate in “Beauty Days”, which is an exclusive ... Roz Kamani’s Kitsilano Skin Care Clinic. It is attended ... patients about the latest products and services that are ...
(Date:4/1/2015)... 2015 Tempaper has joined forces with ... giving campaign that will raise critical funds to help ... disease across the United States. , Throughout the month ... Tempaperdesigns.com will automatically receive free domestic ground shipping ... urgently needed progress to children and adults affected by ...
(Date:4/1/2015)... IQ Formulations , one of the most highly regarded ... U.S., today is commending GNC for taking steps to boost ... herbal supplements.* GNC vowed that its new processes will look ... labeling on its products. , In response to this ... Jay Cohen said: , “In a lightly-regulated industry where ...
Breaking Medicine News(10 mins):Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2
... ... ... ... ...
... ... ... ... ...
... , ... ... ... ...
... ... custom stress balls has started 2010 with two record months which points to an economic ... ... balls has started 2010 with two record months which points to an economic upturn ...
... ctp ... this means for leadership and how it is redefining our understanding of soft skills. ... – all leading to better organisations and higher returns on human investment. , ... (PRWEB) March 2, 2010 ...
... Clinically Relevant Technologies ... management guidelines with the release of new medical iPhone app. , ... (PRWEB) March 2, 2010 -- Clinically Relevant Technologies released a new ... care gap. The release comes on the heels of a study published last month in ...
Cached Medicine News:Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 2Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 3Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 4Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 5Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 6Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 7Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 8Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 9Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 10Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 11Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 12Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 13Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 14Health News:Dental Operatory Equipment and Practice Management Software Market in the U.S. to Reach Almost $2 Billion by 2016 2Health News:Dental Operatory Equipment and Practice Management Software Market in the U.S. to Reach Almost $2 Billion by 2016 3Health News:Dental Operatory Equipment and Practice Management Software Market in the U.S. to Reach Almost $2 Billion by 2016 4Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 2Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 3Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 4Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 5Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 6Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 7Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 8Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 9Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 10Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 11Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 12Health News:Promotional Stress Ball Supplier -- StressBallsUK.com Starts 2010 Strongest Ever 2Health News:Key Leadership Seminar: Maximizing Profit through Social Intelligence - What Neuroscience Tells Us 2Health News:Clinically Relevant Technologies Releases New Medical iPhone App To Fill Gap In Adherence To Low Back Pain Management Guidelines 2
The ENDO CLOSE™ trocar site closure device has application in laparoscopic procedures for approximation of tissues and percutaneous suturing for closing incision sites....
This ENDOLOOP suture has a suture type - 0 PDSII and a 1.5 inch diameter....
... long ligature inserted into a plastic tube. The plastic ... the other. The suture protrudes from the narrow end ... knot which becomes secure after the device is activated. ... the scored end of the plastic tube. The scored ...
... difficile Panel is an enzyme immunoassay used ... antigen (glutamate dehydrogenase) and toxin A in ... as an aid in the diagnosis of ... of the Triage Microbiology product line, designed ...
Medicine Products: